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Summary, Molecular biology allowed considerable improvements in diagnostic procedures by product ion of new and more 
specific sonds for the detection of traces of viruses, both on the nucleic acid and protein levels, and by determining the immune 
response of the host to specific antigens. Improvements in sensitivity and improved correlation to the stage of viral disease are 
already evident from several applications and strongly suggest a broad application of these approaches. 
Key words'. Nucleic acid hybridization; synthetic peptides; computer analysis; antigen selection; recombinant antigens; rapid 
diagnosis, 
Introduction 
Development of virus-specific therapy and the need for fast 
differential diagnosis for intensive medical care challenge 
quick diagnosis which should also allow conclusions for the 
stage of disease. 
Classic methods of viral disease diagnosis are based on the 
cultivation of agents, direct demonstrat ion of viral antigens, 
e.g., by immunofluorescence, and the detection of specific 
antibodies. Many of  the procedures currently in use have the 
disadvantage that the reading of results requires well-trained 
personnel and disease-related advice is often not given or 
comes too late. This is particularly true for chronic neoplas- 
tic or reactivated acute virus-related iseases. Addit ional  
problems arise, e.g. form Hepatitis B, through long transi- 
tions from antigen or ant ibody excesses in connection with a 
complete xclusion of remaining infectiosity. 
Detection of genetic material of viruses by nucleic acid hybridi- 
zation 
LABELS: 
1) Isotopes: H 3, $35, p32, 1125 
2) Reactive groups: Al lylamine-UTP 
3) Haptens: Sulfonylation, Digoxin, Biotin 
INTRODUCTION OF LABELS: 
- nick transl~tJon: for  labels l ,  2, 3 
- random prime: for labels 1, 2, 3 
- eDNA: for labels 1, 2, 3 
- cRNA using SP6 or T7 Polyrnerases with appropriate promotor-containlng vectors: 
for labels 1, 2 "~,  ~ - -  
- chemical modification, e.g. lodination, Photobiotin: 
for labels 1, 3 
- sandwich hybridization: 
for labels 1, 2, 3 
Considerably influenced by the findings of tumor virology, Figure 1. Introduction of label in nucleic acids for use as hybridization 
i.e., that  viruses persist in cells and can change these without probe 1, 7, 8,13,14,16,19, 23, 24 
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Serologic parameter ofEBV-related diseases based on specific proteins produced by recombinant DNA technology. 





IgM BMRF- 1 (EA) IgG BMRF- 1 (EA) 
IgM BcLF- 1 (VCA) 
lgG BcLF- 1 (VCA) 
IgG BKRF-I(EBNA-1) 
IgG BcLF- 1 (VCA) 
(in absence oflgG to BKRF-I (EBNA-1) and/or BLLF-1 MA as well as lgM to BMRF-1) 
IgA BALF-2(EA) IgA BLLF-1 (MA) 
to ta l  HBV DNA pos .  
N N g 
HBE AG pos. 1051 805 77 (20-100) 
Anti HBE pos. 360 141 16 (=-64) 
HBE AG neg., 
Anti HBE neg. 175 36 21 (0-47) 
Figure 2. Detection of HBV-DNA in serum with various serological 
20 parameters (Seelig et al. , including some of our own unpublished data). 
the presence of structural proteins, the detection of viral 
nucleic acids was seen as a useful test for acute and chronic 
active diseases. 
For this method to be widely used, the availability of appro- 
priate probes leaving a detectable signal is an absolute re- 
quirement. Several methods have been applied to introduce a 
label into virus-specific DNA segments, derived almost ex- 
clusively from segments of the viral genomes cloned into the 
appropriate plasmid vectors. As a detection system, [32p]-la- 
beled nucleic acids together with autoradiography are fre- 
quently used because of their low price and high-signal den- 
sity. Non-radioactive d tection systems are being increasingly 
applied as the sensitivity isgradually improved and the possi- 
bilities of long-term storage and reduced environmental pol- 
lution are solved (fig. 1). The requirement tohave a multitude 
of specific probes can cause logistic problems. Introduction 
of specific sequences in bacteriophages with single-stranded 
DNA in combination with labeled universal probes to the 
phage portion allows the economic establishment of a large 
collection of unlabeled yet detectable probes 24. 
In the case of Hepatitis B, viral DNA in serum can be de- 
tected with simple procedures. Serum samples can be applied 
to simple filtration units or directly to membrane filters and 
tested for nucleic acids. Evaluation of test series from several 
laboratories demonstrates that nucleic acid hybridization is
the best proof of potential infectiosity of patients 2~ (fig. 2). 
The difficulties in the diagnosis of acute diseases becomes 
evident with the demonstration f cytomegalovirus in immu- 
nosuppressed individuals uch as organ transplant recipients 
or those infected by human immunodeficiency virus (HIV). 
Several methods have been compared. Virus isolation is too 
slow in any case. Short-term culture and detection of viral 
antigens or nucleic acids in these cultures have a considerably 
accelerated diagnosis which is important in the face of virus- 
specific therapy. Because testing of several samples is usually 
little more work compared to tests with single samples, it 
seems worth the consideration to routinely screen over lon- 
ger periods persons at high risk for cytomegalovirus infec- 
tion for virus release. 
Using the example of bone marrow transplant patients, con- 
siderable variations of virus load could be demonstrated TM ~3. 
A coordination of immunosuppressive th rapy and/or anti- 
viral therapy is possibly more effective than waiting for the 
viral disease to reach its final stages. Important for cytome- 
galovirus-related diagnosis is the use of specific segments of 
viral DNA as a probe for several regions of viral DNA 
cross-reacted with human DNA. In addition, care must be 
taken to avoid false-positive r sults by incorrect preparation 
of test samplesl?. 
Demonstration of viral nucleic acids is of interest and impor- 
tance for virus-associated neoplasias of man, papilloma- 
virus-associated carcinomas (e.g. of the cervix uteri) and 
Epstein-Barr virus (EBV)-associatd nasopharyngeal carci- 
noma (NPC) in particular. Detection of viral genomes can be 
done as described in figure 3. Cellular material can be ob- 
tained from biopsies, swabs m or collected with the help of 
simple aspiration devices i . 
Frequently the distinction, whether tissue or lymph nodes 
represent malignant or benign growth or reactive processes, 
is difficult. In the case of virus-associated condition, the sta- 
tus of viral nucleic acids may allow important conclusions. 
DNA of papillomavirus, for example, is integrated into the 
host genome (fig.4C) in a specifc manner while it is still 
present as a circular molecule (fig. 4B) in warts and condy- 
lomas 4. DNA of EBV in lymphoma cells is present in a 
K1 K2  K3  
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Figure 3. Nucleic acid hybridization for the detection of cy megalovirus 
with urine samples of bone marrow transplant recipients. A low speed and 
a high speed pellet were prepared in consecutive order from 5 ml of urine 
collected at the weeks post transplantation given at each lane. For each 
sample low speed and high speed pellets are tested using a cloned frag- 
ment of CMV-DNA 13. A sample was considered positive when the high 
speed pellet yielded a stronger signal than theow speed pellet. K1 K3 
represent samples taken from three different patients. 
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RE 
I 
circular form (fig. 4B) while cells replicating virus contain 
linear viral genomes (fig. 4A). Differentiation of these forms 
of viral DNA can help to distinguish malignant proliferative 
from reactive forms. 
The tissues to be tested can be analyzed with the help of 
restriction enzymes for the presence of linear, circular or 
integrated viral DNA (fig. 4). 
For diseases involving latency, sensitivity of detection can be 
a serious problem. Besides considerable progress in introduc- 
tion and detection of signals in the hybridization probe 
(fig. 1) 2 , specific amplification of the relevant (viral) se- 
quences in the test material has been developed as a powerful 
enhancement of sensitivity (fig.4) m. The principle of the 
test 12 involves the addition of (synthetic) oligonucleotides 
complementary to two areas of both strands leaving a space 
of a few hundred nucleotides in between. The 'gap' can be 
filled in the presence of the Klenow fragment of DNA poly- 
merase and nucleosidetriphosphates. The use of heat-stable 
DNA polymerase (T. aquaticus) allows several consecutive 
cycles of amplification by a sequence of heating and anneal- 
ing/sequencing steps (fig. 5). 
In the case of NPC it was necessary to correlate the presence 
of viral nucleic acid with the epithelial tumor cells. This was 
possible using frozen tumor sections and hybridizing viral 
DNA to the viral sequences in situ followed by autoradiogra- 
phy 22. This powerful technique was used for a multitude of 
questions and, with appropriate improvements 5, has been 
very useful for elucidation of pathogenetic mechanisms as 
shown for sudden deafness of man 6. 
Immunological procedures 
Classic serological procedures are not at all reduced in the 
overall importance by the possibilities of nucleic acid hy- 
bridization; rather, it becomes evident hat inclusion of anti- 
body class-specific tests and the use of well-characterized 
antigen systems allows considerably improved diagnostic 
judgement. For example, it was possible to develop test sys- 
tems for the EBV-related NPC, which allows early diagnosis 
and which leads to considerable improvements of prognosis. 
The increasing force for rationalization i the laboratories 
and the desire for exact documentation can only be fulfilled 
when pure antigens permitting machine-readable tests are 
available. 
Gene technological methods and chemical synthesis of seg- 
ments of viral gene products offer the possibility of pure 
reagents, even for those agents which are difficult to grow in 
tissue culture. 
RE 
denoture .~/add  primer 
R e v i e w s  
denature I DNA- polymerose 
-&  
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Figure 5. Amplification of selective segments of DNA in test material. 
RE: restriction enzyme site. 
The value of these techniques will be explained on the exam- 
ple of diagnosis of EBV and HIV-related diseases. Immuno- 
fluorescence only rarely allows detection of antibodies for 
specific proteins because these tests are neither machine- 
readable nor available for documentation. Series of immu- 
noprecipitations with radioactive-labeled EBV-infected cells 
using sera from NPC patients, patients with infectious 
mononucleosis and sera from healthy EBV antibody-posi- 
tive individuals were made in order to identify those viral 
proteins which seemed useful for identification of the partic- 
ular health status due to the regular presence of the respective 
antibodies. 
Parallel to the selection of antigens, proteins were mapped on 
the viral genome using hybridselected translation2< The 
identified genes were then cloned into bacterial plasmids 
such that transfected bacteria would produce these products. 
Because many viral proteins are not stable in heterologous 
expression systems, strategies were developed which allowed 
the identification of those protein segments responsible for 
their recognition by the immune system and to selectively 
express these segments (fig. 6) ~s. Repeated application of this 
, , ' ,~ '~ ~,~ ~.,, 
A B C 
_ _  a - -  a _ _ a  
............... b + C ~ b+z2 
.............. c t z 1 - -  b 
.............. c 
Figure 4. Detection of the stage of viral DNA in infected tissue. Extracted 
total DNA is digested with the appropriate r striction enzymes, electro- 
phoretically separated by molecular weight on agarose gels, transferred to
membranes and hybridized with a specific fragment of the viral genome. 
The hatched band will be the only one visible in the excess of cellular 
DNA through the hybridization detection and by its molecular weight 
directed location allow the distinction of the stages of viral DNA 17. 
FR I I I  
L 
250 
FR IV  
F RV 
FRV l l  
~ C O O H  
Figure 6. Computer analysis of an EBV gene (p138; BALF-2 EA). Pre- 
diction of secondary structure (c~ helix ~,  pleated sheet ~aM/, random 
coil /~A and fl-turn ~ ) with various algorithms (e.g. Refs. 3, 9) are 
superimposed with further parameters, here hydropathy (9 hydrophilic, 
hydrophobie). Areas with fl-turns in hydrophilic environment were 
found to be preferred areas for eliciting humoral immune response 2s. FR 
IVII: subcloned fragments ofthe p 138 gene. 
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technology allowed the development of antigen kits which 
permit diagnosis of various diseases caused by EBV (table). 
The described approach is of special importance also for 
diagnosis of HIV infections. Because Western blots derived 
from viruses are often difficult to interpret due to the pres- 
ence of diffuse bands of glycoproteins and variations in qual- 
ity. With respect o the security concerns for mass cultures of 
HIV, tests have been developed on the basis of recombinant 
products. A combinat ion of such products allows definite 
diagnosis even in questionable cases (Soutschek-Bauer, 
Motz and Wolf, in prep,). At  the same time recombinant 
antigens, which may contain the major antigenic deter- 
minant  of viral proteins, can be the source of inexpensive and 
simple first screening tests (Motz, Soutschek-Bauer and 
Wolf, in prep.). 
One alternative to antigens produced by gene technology is 
the chemical synthesis of peptides. A disadvantage of this 
method is that only short segments of a protein can be repre- 
sented. Appl ication of appropriate computer programs for 
epitope selection and the use of several antigens in one test 
can very effectively limit these disadvantages 25.An advan- 
tage of this method is that no problems with foreign antigens 
exist and that antigens become available shortly after a se- 
quence of a gene is finished. This then becomes particularly 
evident when a new technique for synthesis is used. With this 
method peptides are linked via ester bondage so stably to the 
carrier that  they remain bound even through removal of the 
protective groups (Modrow and Wolf, in prep.). It is a fea- 
ture of this method that peptides need not be removed from 
the carrier followed by t ime-consuming purif ication and 
consequent binding to surfaces which always causes the re- 
duction of antigenicity. Thus fast and inexpensive test sys- 
tems can be developed when simple pieces of equipment such 
as the millititer system from Mill ipore is used (fig. 7). 
membrane- sealed 96-wel l  plate 
standard 96-well plate 
vacuum 
Figure 7. Solid phase ELISA test with peptide antigen coupled to resin 
beads (Modrow and Wolf, in prep.). Using modifications of Fmoc and 
tBoc chemistry of peptide synthesis resins containing deprotected oligo- 
peptides can be produced. These particles can be used in suspension to 
react with antibodies from serum samples and thus allow the development 
of diagnostic tests. The use of microtiter plates with membrane-mounted 
bottom including a fitted suction device for both incubation and washing 
greatly facilitates this technique of antibody detection. 
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